Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Complex cases of diabetic retinopathy, retinal detachments, proliferative vitreoretinopathy, giant retinal tears and trauma cases usually demand vitreous surgery for repair. In such cases, intraocular tamponades plays a vital role in providing support to the retina and preventing the passage of fluid through the retinal breaks.

Statistics:

The global vitreous tamponades market is estimated to account for US$ 92.3 Mn in terms of value by the end of 2027.

Global Vitreous Tamponades Market: Drivers

Increasing prevalence of diabetic retinopathy is expected to propel growth of the global vitreous tamponades market over the forecast period. For instance, according to the National Diabetes and Diabetic Retinopathy Survey report published in October 2019, the prevalence of diabetes in India was 11.8% during 2015-2019 and the prevalence of known diabetes cases was 8.0% and new diabetes cases was 3.8% during the period.

Moreover, increasing geriatric population is also expected to boost demand for vitreous tamponades. For instance, according to the World Health Organization, geriatric population is expected to reach 2 billion by 2050, up from 900 million in 2015.  

Statistics:

North America held dominant position in the global vitreous tamponades market in 2019, accounting for 33.1% share in terms of value, followed by Europe and Asia Pacific, respectively.

Figure 1: Global Vitreous Tamponades Market Share (%) Value, By Region, 2019

Vitreous Tamponades  | Coherent Market Insights

Global Vitreous Tamponades Market: Restraints

Commoditization of the vitreous tamponades industry in Europe, Asia Pacific, and RoW is expected to hinder growth of the global vitreous tamponades market. Rising demand for effective long-term tamponades and increasing number of manufacturers (especially penetration by local manufacturers who offer tamponades at lower prices) in the tamponades market has spurred a price war, which is adversely affecting industry revenue. Although the shift from high-priced to low-priced products enables distributors to record higher profit margins, it affects the overall vitreous tamponades market.

Moreover, reduced R&D expenditure by companies, resulting in lack of product innovation is also expected to limit the market growth.

request-sample

Vitreous Tamponades Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 76.0 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 2.5% 2027 Value Projection: US$ 92.3 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
  • Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: North Africa, Central Africa, South Africa
Segments covered:
  • By Product Type:
    • Gases: Silicone Oil, PFCL.
    • Liquid
Companies covered:

Alchimia srl, Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Croma-Pharma GmbH, Dutch Ophthalmic Research Center (International) B.V., and Fluoron GmbH

Growth Drivers:
  • Increasing prevalence of diabetic retinopathy
  • Approval and launch of new products
Restraints & Challenges:
  • Risk of complication

Global Vitreous Tamponades Market: Opportunities  

R&D in vitreous tamponades is expected to offer lucrative growth opportunities for players in the global vitreous tamponades market. Currently, silicone oil, perfluorocarbon (PFCL) or gaseous tamponades are used for the treatment of retinal detachment disorders. Conventional silicone oil (specific gravity of 0.95 g/cm3 to 0.98 g/cm3) is used during the treatment of superior retina breaks, while heavy silicone oil (specific gravity of 1.02 g/cm3 to 1.06 g/cm3) is used during the treatment of inferior retina breaks. However, the treatment of proliferative vitreoretinopathy and multiple breaks both in upper and lower retina remains clinically challenged. This is because conventional silicone oil floats in upper vitreous cavity and leaves the lower vitreous cavity without any effective support. Similarly, heavy silicone oil, which is ideal for the treatment of retinal break in lower vitreous cavity, leaves the upper cavity without support.

Moreover, development of innovative products in future is also expected to aid in growth of the global vitreous tamponades market.

Statistics:

The global vitreous tamponades market was valued at US$ 76.0 Mn in 2019 and is forecast to reach a value of US$ 92.3 Mn by 2027 at a CAGR of 2.5% between 2020 and 2027.

Figure 2: Global Vitreous Tamponades Market Value (US$ Mn), 2016 – 2027

Vitreous Tamponades  | Coherent Market Insights

Market Trends/Key Takeaways

Silicone oil is one of the most commonly used tamponade agents in vitreoretinal surgeries. However, there are multiple adverse effects and complications of silicone oil such as secondary angle closure congestion, and anterior rotation of the ciliary body.

Major players in the global vitreous tamponades market are focused on strengthening its position in the market. For instance, in March 2020, Alchimia srl announced the incorporation of Alchilife Srl, an Italian Research & Development company specialized in the ophthalmic field.

Figure 03: Value Chain Analysis

Vitreous Tamponades  | Coherent Market Insights

Global Vitreous Tamponades Market: Competitive Landscape

Major players operating in the global vitreous tamponades market include, Alchimia srl, Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Croma-Pharma GmbH, Dutch Ophthalmic Research Center (International) B.V., and Fluoron GmbH.

Global Vitreous Tamponades Market: Key Developments

Major players in the global vitreous tamponades market are focused on adopting M&A strategies to expand their product portfolio. For instance, in December 2018, Alcon, Inc. acquired Tear Film Innovations, Inc., a privately-held company and manufacturer of the iLux Device, a therapeutic device used to treat Meibomian Gland Dysfunction, a leading cause of dry eye.

Vitreous tamponades are essentials used in vitrectomy procedures for healing or reattachment of retina and in vitreous dysfunction. These are used majorly used in various retinal disorders such as retinal detachment, diabetic retinopathy, retinitis pigmentosa, retinal degeneration, vascular occlusion, macular hole, epiretinal membrane, macular edema, uveitis, and retinopathy of prematurity. Increasing prevalence of diabetic retinopathy along with increasing research and development for new efficient product is expected to drive the market growth during the forecasted period.

Key features of the study:

  • This report provides in-depth analysis of the Global Vitreous Tamponades market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Vitreous Tamponades market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Alchimia srl, Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Croma-Pharma GmbH, Dutch Ophthalmic Research Center (International) B.V., and Fluoron GmbH.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Vitreous Tamponades market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Vitreous Tamponades market

Detailed Segmentation:

  • Global Vitreous Tamponades Market, By Product Type:
    • Gases
      • Silicone Oil
      • PFCL
    • Liquid
  • Global Vitreous Tamponades Market, By Region:
    • North America
      • By Product Type:
        • Gases
          • Silicone Oil
          • PFCL
        • Liquid
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Gases
          • Silicone Oil
          • PFCL
        • Liquid
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Gases
          • Silicone Oil
          • PFCL
        • Liquid
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Gases
          • Silicone Oil
          • PFCL
        • Liquid
      • By Country
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Gases
          • Silicone Oil
          • PFCL
        • Liquid
      • By Country
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Gases
          • Silicone Oil
          • PFCL
        • Liquid
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Alchimia srl *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Alcon, Inc.
    • Bausch Health Companies Inc.
    • Carl Zeiss Meditec AG
    • Croma-Pharma GmbH
    • Dutch Ophthalmic Research Center (International) B.V.
    • Fluoron GmbH
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Country
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Global Vitreous Tamponades Market, By Product Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Gases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Silicone Oil
        • PFCL
    • Liquid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Vitreous Tamponades Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  6. Competitive Landscape
    • Company Profiles
      • Alchimia srl
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Alcon Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bausch Health Companies Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Carl Zeiss Meditec AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Croma-Pharma GmbH
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Dutch Ophthalmic Research Center (International) B.V
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fluoron GmbH
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  7. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 14 figures on “Vitreous Tamponades Market - Global forecast to 2027”.

Frequently Asked Questions

The Global Vitreous Tamponades market size was valued at US$ 76.0 million in 2019 and is estimated to exhibit a CAGR of 2.5% between 2020 and 2027.
Liquid vitreous tamponades segment held the major market share in 2019 owing to increasing prevalence of diabetic retinopathy is expected to propel growth of the global vitreous tamponades market over the forecast period.
Major factor driving the growth of Global Vitreous Tamponades market during the forecast period increasing prevalence of diabetic retinopathy, increasing research & development , and adoption of expansion strategies from major companies.
Major factors hampering the growth of the Global Vitreous Tamponades market during the forecast period constitutes of disadvantages such as risk of complication
North America market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Alchimia srl, Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Croma-Pharma GmbH, Dutch Ophthalmic Research Center (International) B.V., and Fluoron GmbH
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner